132 related articles for article (PubMed ID: 7342848)
1. Normovolemic hemodilution in peripheral arterial disease.
Rieger H; Köhler M; Schoop W; Schmid-Schönbein H
Ann Clin Res; 1981; 13 Suppl 33():78-83. PubMed ID: 7342848
[TBL] [Abstract][Full Text] [Related]
2. Hemodilution (HD) in patients with ischemic skin ulcers.
Rieger H; Köhler M; Schoop W; Schmid-Schönbein H; Roth FJ; Leyhe A
Klin Wochenschr; 1979 Nov; 57(21):1153-61. PubMed ID: 513607
[TBL] [Abstract][Full Text] [Related]
3. [Can normovolemic hemodilution really modify blood flow in the limbs?].
Guerrini M; Pieragalli D; Acciavatti A; Cappelli R; Pecchi S; Forconi S; Di Perri T
Ric Clin Lab; 1983; 13 Suppl 3():439-44. PubMed ID: 6673027
[TBL] [Abstract][Full Text] [Related]
4. [Hyper- or isovolemic hemodilution in patients with stage II peripheral arterial occlusive disease].
Kiesewetter H; Jung F; Blume J; Spitzer S; Birk A
Acta Med Austriaca; 1991; 18 Suppl 1():23-7. PubMed ID: 1719729
[TBL] [Abstract][Full Text] [Related]
5. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
6. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Gerhards M; Waldhausen P; Wenzel E
Wien Med Wochenschr; 1989 Sep; 139(17):396-401. PubMed ID: 2480029
[TBL] [Abstract][Full Text] [Related]
7. [Hemodynamics in controlled normovolemic hemodilution in patients with obliterative vascular diseases].
Kuznetsov NA
Vestn Khir Im I I Grek; 1986 Feb; 136(2):126-31. PubMed ID: 3518191
[TBL] [Abstract][Full Text] [Related]
8. [Hemorheologic therapy in peripheral arterial occlusive disease].
Kiesewetter H; Jung F
Fortschr Med; 1984 Oct; 102(37):921-4. PubMed ID: 6500451
[TBL] [Abstract][Full Text] [Related]
9. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Spitzer S; Bach R; Birk A; Schieffer H; Wenzel E
Schweiz Med Wochenschr; 1989 Dec; 119(51):1862-7. PubMed ID: 2481883
[TBL] [Abstract][Full Text] [Related]
10. [Hemodilution in peripheral arterial occlusive disease--study comparing 3 different variants of hemodilution].
Weidinger P; Bilek M; Tekusch A
Vasa Suppl; 1990; 30():137-8. PubMed ID: 2075564
[No Abstract] [Full Text] [Related]
11. [Hypervolemic hemodilution with medium molecular-weight hydroxyethyl starch: effect of duration of administration on viscoelasticity of blood in IIa and IIb peripheral arterial occlusive disease].
Költringer P; Langsteger W; Lind P; Klima G; Pierer G; Reisecker F; Eber O
Acta Med Austriaca; 1991; 18 Suppl 1():45-7. PubMed ID: 1719731
[TBL] [Abstract][Full Text] [Related]
12. Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia.
Hafner J; Schaad I; Schneider E; Seifert B; Burg G; Cassina PC
J Am Acad Dermatol; 2000 Dec; 43(6):1001-8. PubMed ID: 11100015
[TBL] [Abstract][Full Text] [Related]
13. [Experiences with the clinical use of iso- and hypervolemic hemodilution in conservative therapy of vascular diseases].
Turowski A; Schmidt H; Sternitzky R; Brehme S; Keysser G; Hiebsch G; Hiebsch U
Vasa Suppl; 1991; 32():338-41. PubMed ID: 1771528
[No Abstract] [Full Text] [Related]
14. Hypervolemic hemodilution with or without venesection in peripheral arterial occlusive disease stage II.
Kiesewetter H; Jung F; Birk A; Spitzer S
Int Angiol; 1994 Mar; 13(1):1-4. PubMed ID: 8077790
[TBL] [Abstract][Full Text] [Related]
15. [Dynamics of regional blood circulation in normovolemic hemodilution in patients with arterial occlusive diseases].
Kuznetsov NA; Bogdanov AE
Vestn Khir Im I I Grek; 1987 Sep; 139(9):19-24. PubMed ID: 3441964
[TBL] [Abstract][Full Text] [Related]
16. [Survey on adherence to hygiene and dietary rules in patients with arterial occlusive disease].
Aligne C; Mosnier M; Mistretta F; Larguier JS
J Mal Vasc; 2000 Jun; 25(3):187-94. PubMed ID: 10906634
[TBL] [Abstract][Full Text] [Related]
17. Lower extremity arterial and venous ulcers.
Sieggreen M
Nurs Clin North Am; 2005 Jun; 40(2):391-410. PubMed ID: 15924901
[TBL] [Abstract][Full Text] [Related]
18. [Anti-thixotropic therapy in arterial occlusive disorders: What is the effectiveness of "rheological procedures" in the presence of persisting obliterations?].
Schmid-Schönbein H
Wien Med Wochenschr; 1985 Aug; 135(15-16):368-79. PubMed ID: 4060740
[TBL] [Abstract][Full Text] [Related]
19. [Ambulatory hemodilution therapy of peripheral arterial circulation disorders].
Wohlleben E; Wohlleben H; Voigt H; Köhler H
Z Gesamte Inn Med; 1981 Nov; 36(21):838-9. PubMed ID: 7331388
[TBL] [Abstract][Full Text] [Related]
20. [Blood rheology in peripheral occlusive disease. Effects of hemodilution and pentoxifylline].
Angelkort B
Wien Med Wochenschr; 1986; 136 Spec No():29-35. PubMed ID: 3548089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
